Publicaciones en las que colabora con José Alberto Fernández Villar (15)

2023

  1. Evolution and long‑term respiratory sequelae after severe COVID-19 pneumonia: nitric oxide diffusion measurement value

    Respiratory Research, Vol. 24, Núm. 1

2021

  1. Alterations in respiratory function test three months after hospitalisation for covid-19 pneumonia: Value of determining nitric oxide diffusion

    Journal of Clinical Medicine, Vol. 10, Núm. 10

  2. Key Pulmonology and Thoracic Surgery Issues under Discussion in the COVID-19 Era

    Open Respiratory Archives, Vol. 3, Núm. 4

  3. Lung Ultrasound to Predict Unfavorable Progress in Patients Hospitalized for COVID-19

    Archivos de Bronconeumologia, Vol. 57, pp. 47-54

2016

  1. Validation of the 'Test of the Adherence to Inhalers' (TAI) for Asthma and COPD Patients

    Journal of Aerosol Medicine and Pulmonary Drug Delivery, Vol. 29, Núm. 2, pp. 142-152

2014

  1. Aproximación al tratamiento de la EPOC según la Guía GesEPOC

    Cadernos de atención primaria, Vol. 20, Núm. 1, pp. 51-64

2013

  1. Aforismos sobre Enfermedad Pulmonar Obstructiva Crónica e Insuficiencia Cardíaca

    Galicia Clínica, Vol. 74, Núm. 3, pp. 111-114

2008

  1. Influence of glutathione S-transferase M1 and T1 homozygous null mutations on the risk of antituberculosis drug-induced hepatotoxicity in a Caucasian population

    Liver International, Vol. 28, Núm. 6, pp. 835-839

2007

  1. Derrame pleural tipo trasudado como expresión de afectación pleural por amiloidosis

    Revista Clinica Espanola

  2. Hepatitis C virus RNA in serum as a risk factor for isoniazid hepatotoxicity [4]

    Infection

  3. Hepatitis C virus infection and isoniazid hepatotoxicity [5]

    Chest

  4. Multidrug-resistant tuberculosis in a low-incidence region shows a high rate of transmission

    International Journal of Tuberculosis and Lung Disease, Vol. 11, Núm. 4, pp. 429-435

2005

  1. Study of Mycobacterium tuberculosis drug resistance in the region of Galicia, Spain

    International Journal of Tuberculosis and Lung Disease, Vol. 9, Núm. 11, pp. 1230-1235

2004

  1. The influence of risk factors on the severity of anti-tuberculosis drug-induced hepatotoxicity

    International Journal of Tuberculosis and Lung Disease, Vol. 8, Núm. 12, pp. 1499-1505

2003

  1. Isoniazid hepatotoxicity among drug users: The role of hepatitis C

    Clinical Infectious Diseases, Vol. 36, Núm. 3, pp. 293-298